Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-Term, Open-Label Safety Study of Oral Almotriptan Malate 12.5 mg in the Treatment of Migraine in Adolescents

NCT00257010 is registered in ClinicalTrials.gov with Janssen-Ortho LLC as lead sponsor.

NCT NCT00257010
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00257010 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-Term, Open-Label Safety Study of Oral Almotriptan Malate 12.5 mg in the Treatment of Migraine in Adolescents
Lead sponsor
Janssen-Ortho LLC
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2005
Completion date
December 31, 2007
Enrollment
447 (actual)
Sites
49

Conditions

As the registry lists them; a condition with its own page is linked.

migraine